Structure (Figure1)
Purixan Suspension
Product Images NDC 62484-0020
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Purixan (NDC 62484-0020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nova Laboratories, Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Purixan Bottle Label (Bottle Label)
Purixan Carton Label (Carton Label)
This text contains information related to a medicine called Purixan. It is sold in bottles containing 2000mg/100mL, in oral suspension form with a pillbox reference of A01680. The bottle needs to be shaken vigorously for at least 30 seconds before using it, and it should be kept at room temperature up to 25°C (77°F) in a dry place. It has been manufactured by Nova Laboratories Ltd for Rare Disease Therapeutics in Franklin, Tennessee, United States. Inactive ingredients include xanthan gum, aspartame, concentrated raspberry juice, sucrose, ethyl parahydroxybenzoate sodium, methyl parahydroxybenzoate sodium, potassium sorbate, sodium hydroxide, and purified water. It also provides the NDC codes for different pack sizes of the product.*
Figure A (Nova 04)
Figure B (Nova 05)
Figure C (Nova 06)
Figure E (Nova 07)
Figure F (Nova 08)
Figure D (Nova 09)
Purixan Serialized Carton Example
Pu rixan Oral suspension is a medication with 2000mg/100mL concentration of the active ingredient mercaptopurine. It comes with an NDC code L24B4-D020-2 and a lot number of 1333pFOpE. The medication has an expiry date of July 2015. The last line of the text is not readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
